Phase II clinical trial of cisplatin (CDDP), 5-Fluorouracil (5-FU) and ifosfamide (IFX) as treatment for advanced locoregional head and neck carcinoma (AHNC)

被引：0
|
作者：
Parra, MS
Churruca, C
Paredes, A
Lacasta, A
de Argumedo, GL
Alvarez, I
Abad, T
Egana, L
Iriarte, L
Urraca, JM
Piera, JM
机构：
[1] Hosp No So Aranzazu, Med Oncol Unit, San Sebastian, Spain
[2] Hosp No So Aranzazu, Radiotherapy Unit, San Sebastian, Spain
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
380
引用
收藏
页码：79 / 79
页数：1
相关论文
共 50 条
  • [1] Phase II clinical trial of cisplatin, 5-fluorouracil, and ifosfamide as treatment for advanced locoregional head and neck carcinoma
    Parra, MS
    Churruca, C
    Paredes, A
    Lacasta, A
    de Argumedo, GL
    Alvárez, I
    Abad, T
    Egana, L
    Guimón, E
    Piera, JM
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1999, 22 (01): : 6 - 7
  • [2] Concomitant radiochemotherapy with cisplatin (CDDP), 5-fluorouracil (5-FU) and mitomycin C (MMC) in locally advanced oropharyngeal carcinoma: Results of a phase II trial
    Berger, C
    Chapet, S
    Calais, G
    ReynaudBougnoux, A
    Garand, G
    LeFloch, O
    BULLETIN DU CANCER, 1995, 82 (12) : 1044 - 1051
  • [3] SALVAGE TREATMENT WITH CISPLATIN (CDDP) AND 5-FLUOROURACIL (5-FU) IN ADVANCED BREAST-CANCER PATIENTS
    PRONZATO, P
    AMOROSO, D
    BERTELLI, G
    LIONETTO, R
    ARDIZZONI, A
    CONTE, PF
    ROSSO, R
    GALLOTTI, P
    BREAST CANCER RESEARCH AND TREATMENT, 1987, 10 (01) : 108 - 108
  • [4] A RANDOMIZED TRIAL OF CISPLATIN (CACP) + 5-FLUOROURACIL (5-FU) INFUSION AND CACP + 5-FU BOLUS FOR RECURRENT AND ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    KISH, JA
    ENSLEY, JF
    JACOBS, J
    WEAVER, A
    CUMMINGS, G
    ALSARRAF, M
    CANCER, 1985, 56 (12) : 2740 - 2744
  • [5] Phase II study of 5-fluorouracil (5-Fu), cisplatin (CDDP) and vinorelbine (VNR) in patients (pts) with advanced adenocarcinoma of oesophagus.
    Vicent, JM
    García-Girón, C
    Feliu, J
    Berrocal, A
    Camps, C
    Barón, G
    Lara, MA
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S76 - S76
  • [6] A phase II randomized study of cisplatin (CDDP), tomudex (TOM), levofolinic acid (LFA) and 5-fluorouracil (5-FU) versus CDDP, methotrexate (MTX), LFA, and 5-FU in locally advanced (LAD) or metastatic (M) head and neck cancer (HNC)
    Caponigro, F
    Rosati, G
    Avallone, A
    Butillon, A
    Manzione, L
    De Lucia, L
    Rivellini, F
    Guida, T
    Mantovani, G
    Comella, P
    Comella, G
    ANNALS OF ONCOLOGY, 2000, 11 : 2 - 2
  • [7] Does cisplatin (CDDP) function as a modulator of 5-fluorouracil (5-FU) antitumor action? A study based on a clinical trial
    Matsusaka, S
    Nagareda, T
    Yamasaki, H
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2005, 55 (04) : 387 - 392
  • [8] Does cisplatin (CDDP) function as a modulator of 5-fluorouracil (5-FU) antitumor action? A study based on a clinical trial
    Satoshi Matsusaka
    Tomofumi Nagareda
    Hajime Yamasaki
    Cancer Chemotherapy and Pharmacology, 2005, 55 : 387 - 392
  • [9] Combination of 5-fluorouracil (5-FU) and cisplatin (P) as chemotherapy for carcinomas in head and neck regions
    Salgado, M
    García-Mata, J
    Fírvida, JL
    Rodríguez, MR
    Montanos, MJ
    1ST WORLD CONGRESS ON HEAD AND NECK ONCOLOGY, 1998, : 975 - 979
  • [10] Cisplatin (CDDP), raltitrexed (Tomudex, TOM), levofolinic acid (LFA) and 5-fluorouracil (5-FU) versus CDDP, methotrexate (MTX), LFA, and 5-FU in locally advanced (LAD) or metastatic (M) head and neck cancer (HNC). A phase II randomized study.
    Caponigro, F
    Rosati, G
    Avallone, A
    De Lucia, L
    Rivellini, F
    Guida, T
    Mantovani, G
    Manzione, L
    Comella, P
    Comella, G
    ANNALS OF ONCOLOGY, 2000, 11 : 90 - 90
12345